Top upgrades and downgrades on 7/6: MRK, EOG, ABT, UNP and more

Analysts Notebook wrote a column · Jul 6, 2022 20:10

Upgrades

• $A.O. Smith (AOS.US)$ : Longbow Research Upgrades to Buy from Neutral - PT $71

• $Callon Petroleum (CPE.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $75

• $Dun & Bradstreet (DNB.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)

• $Enanta Pharmaceuticals (ENTA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)

• $Corning (GLW.US)$ : CFRA Upgrades to Strong Buy from Buy - PT $47

• $Mercer International (MERC.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $18.50)

• $Merck & Co (MRK.US)$ : Daiwa Securities Upgrades to Outperform from Hold - PT $102 (from $89)

• $Rocket (RKT.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $10 (from $6.50)

• $Sabre (SABR.US)$ : BofA Securities Upgrades to Buy from Underperform - PT $10

• $Sempra Energy (SRE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $167 (from $164)

Downgrades

• $Continental Resources (CLR.US)$ : RBC Downgrades to Sector Perform from Outperform - PT $80 (from $75)

• $Coinbase (COIN.US)$ : Atlantic Equities Downgrades to Neutral from Overweight - PT $54 (from $95)

• $Edison International (EIX.US)$ : UBS Downgrades to Neutral from Buy - PT $68 (from $73)

• $EOG Resources (EOG.US)$ : RBC Downgrades to Sector Perform from Outperform - PT $150

• $HCA Healthcare (HCA.US)$ : BMO Capital Downgrades to Underperform from Market Perform - PT $160 (from $233)

• $Pioneer Natural Resources (PXD.US)$ : RBC Downgrades to Sector Perform from Outperform - PT $290

• $RingCentral (RNG.US)$ : Needham Downgrades to Hold from Buy

• $SAP SE (SAP.US)$ : Barclays Downgrades to Equalweight from Overweight - PT $108 (from $142)

• $Union Pacific (UNP.US)$ : Susquehanna Downgrades to Neutral from Positive - PT $235 (from $310)

• $Vmware (VMW.US)$ : Raymond James Downgrades to Market Perform from Outperform

Initiated

• $Abbott Laboratories (ABT.US)$ : Wolfe Research initiates at Underperform - PT $95

• $Avid Technology (AVID.US)$ : JPMorgan initiates at Overweight - PT $33

• $Boston Scientific (BSX.US)$ : Wolfe Research initiates at Outperform - PT $43

• $Definitive Healthcare (DH.US)$ : Needham initiates at Buy - PT $30

• $Fusion Pharmaceuticals (FUSN.US)$ : William Blair initiates at Outperform

• $Howmet Aerospace (HWM.US)$ : Truist Securities initiates at Buy - PT $41

• $Medtronic (MDT.US)$ : Wolfe Research initiates at Underperform - PT $85

• $Materion (MTRN.US)$ : CL King initiates at Buy - PT $95

• $POINT Biopharma (PNT.US)$ : William Blair initiates at Outperform

• $Teleflex (TFX.US)$ : Wolfe Research initiates at Outperform - PT $300

Moomoo Inc. ("moomoo") provides mobile and online technology solutions for securities trading. Moomoo is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of moomoo, its affiliates, or any employees of moomoo or its affiliates. Please consult a qualified investment or tax advisor for your personal financial planning and tax situations.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more